Role of tissue factor in cancer

Journal of Clinical Oncology

Volumn 27, Issue 29, 2009, Pages 4834-4838

  Kasthuri, Raj S ^a   Taubman, Mark B ^a   Mackman, Nigel ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 7A; FIBRIN; PROCOAGULANT; PROTEINASE ACTIVATED RECEPTOR 2; THROMBOPLASTIN; TUMOR MARKER;

ANGIOGENESIS; BLOOD CLOTTING; CANCER GROWTH; CANCER PATIENT; CELL ACTIVATION; ENDOTHELIUM CELL; HUMAN; METASTASIS; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; THROMBOSIS; TUMOR CELL; TUMOR MODEL; TUMOR VASCULARIZATION; VENOUS THROMBOEMBOLISM; ANIMAL; CANCER INVASION; DISEASE COURSE; DISEASE MODEL; EPIDEMIOLOGY; FEMALE; HOSPITALIZATION; MALE; METABOLISM; MORTALITY; MOUSE; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; SURVIVAL; TUMOR VOLUME; VEIN THROMBOSIS;

ANIMALS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FACTOR VIIA; FEMALE; HUMANS; MALE; MICE; NEOPLASM INVASIVENESS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RECEPTOR, PAR-2; SAMPLING STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; THROMBOPLASTIN; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL; VENOUS THROMBOSIS;

EID: 70350706156     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2009.22.6324     Document Type: Review

References (63)

1. Mackman N: Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol 24:1015-1022, 2004
2. Coughlin SR: Thrombin signaling and proteaseactivated receptors. Nature 407:258-264, 2000
3. Mackman N: Regulation of the tissue factor gene. FASEB J 9:883-889, 1995
4. Osterud B, Bjorklid E: Sources of tissue factor. Semin Thromb Hemost 32:11-23, 2006
5. Marmur JD, Rossikhina M, Guha A, et al: Tissue factor is rapidly induced in arterial smooth muscle after balloon injury. J Clin Invest 91:2253-2259, 1993
6. Solovey A, Gui L, Key NS, et al: Tissue factor expression by endothelial cells in sickle cell anemia. J Clin Invest 101:1899-1904, 1998
7. Mackman N, Tilley RE, Key NS: Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler Thromb Vasc Biol 27:1687-1693, 2007
8. Morel O, Toti F, Hugel B, et al: Procoagulant microparticles: Disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol 26:2594-2604, 2006
9. Butenas S, Bouchard BA, Brummel-Ziedins KE, et al: Tissue factor activity in whole blood. Blood 105:2764-2770, 2005
10. Giesen PL, Rauch U, Bohrmann B, et al: Blood-borne tissue factor: Another view of thrombosis. Proc Natl Acad Sci U S A 96:2311-2315, 1999
11. Mackman N: Alternatively spliced tissue factor - one cut too many? Thromb Haemost 97:5-8, 2007
12. Nieuwland R, Berckmans RJ, Rotteveel-Eijkman RC, et al: Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant. Circulation 96:3534-3541, 1997
13. Gregory SA, Morrissey JH, Edgington TS: Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. Mol Cell Biol 9:2752-2755, 1989
14. Morrissey JH, Drake TA, Schlag G: Procoagulant response of the endothelium and monocytes. New York, NY, Springer-Verlag, 1993
15. Pawlinski R, Pedersen B, Schabbauer G, et al: Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia. Blood 103: 1342-1347, 2004
16. Parry GCN, Mackman N: Transcriptional regulation of tissue factor expression in human endothelial cells. Arterioscler Thromb Vasc Biol 15:612-621, 1995
17. Drake TA, Cheng J, Chang A, et al: Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis. Am J Pathol 142:1458-1470, 1993
18. Lupu C, Westmuckett AD, Peer G, et al: Tissue factor-dependent coagulation is preferentially up-regulated within arterial branching areas in a baboon model of Escherichia coli sepsis. Am J Pathol 167:1161-1172, 2005
19. Heit JA: Cancer and venous thromboembolism: Scope of the problem. Cancer Control 12:5-10, 2005 (suppl 1)
20. Sorensen HT, Mellemkjaer L, Olsen JH, et al: Prognosis of cancers associated with venous thromboembolism. N Engl J Med 343:1846-1850, 2000
21. Rickles FR, Hair GA, Zeff RA, et al: Tissue factor expression in human leukocytes and tumor cells. Thromb Haemost 74:391-395, 1995
22. Kakkar AK, Lemoine NR, Scully MF, et al: Tissue factor expression correlates with histological grade in human pancreatic cancer. Br J Surg 82: 1101-1104, 1995
23. White RH, Chew H, Wun T: Targeting patients for anticoagulant prophylaxis trials in patients with cancer: Who is at highest risk? Thromb Res 120: S29-S40, 2007 (suppl 2)
24. Khorana AA, Ahrendt SA, Ryan CK, et al: Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer. Clin Cancer Res 13:2870-2875, 2007
25. Uno K, Homma S, Satoh T, et al: Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer. Br J Cancer 96:290-295, 2007
26. Rauch U, Antoniak S, Boots M, et al: Association of tissue-factor upregulation in squamous-cell carcinoma of the lung with increased tissue factor in circulating blood. Lancet Oncol 6:254, 2005
27. Del Conde I, Bharwani LD, Dietzen DJ, et al: Microvesicle-associated tissue factor and Trousseau's syndrome. J Thromb Haemost 5:70-74, 2007
28. Sato T, Tsujino I, Ikeda D, et al: Trousseau's syndrome associated with tissue factor produced by pulmonary adenocarcinoma. Thorax 61:1009-1010, 2006
29. Dvorak HF, Van DeWater L, Bitzer AM, et al: Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells. Cancer Res 43:4434-4442, 1983
30. Ma L, Francia G, Viloria-Petit A, et al: In vitro procoagulant activity induced in endothelial cells by chemotherapy and antiangiogenic drug combinations: Modulation by lower-dose chemotherapy. Cancer Res 65:5365-5373, 2005
31. Swystun LL, Shin LY, Beaudin S, et al: Chemotherapeutic agents doxorubicin and epirubicin induce a procoagulant phenotype on endothelial cells and blood monocytes. J Thromb Haemost 7:619-626, 2009
32. Lechner D, Kollars M, Gleiss A, et al: Chemotherapy-induced thrombin generation via procoagulant endothelial microparticles is independent of tissue factor activity. J Thromb Haemost 5:2445-2452, 2007
33. Yu JL, May L, Lhotak V, et al: Oncogenic events regulate tissue factor expression in colorectal cancer cells: Implications for tumor progression and angiogenesis. Blood 105:1734-1741, 2005
34. Davila M, Amirkhosravi A, Coll E, et al: Tissue factor-bearing microparticles derived from tumor cells: Impact on coagulation activation. J Thromb Haemost 6:1517-1524, 2008
35. Yu J, May L, Milsom C, et al: Contribution of host-derived tissue factor to tumor neovascularization. Arterioscler Thromb Vasc Biol 28:1975-1981, 2008
36. Tesselaar ME, Romijn FP, Van Der Linden IK, et al: Microparticle- associated tissue factor activity: A link between cancer and thrombosis? J Thromb Haemost 5:520-527, 2007
37. Hron G, Kollars M, Weber H, et al: Tissue factor-positive microparticles: Cellular origin and association with coagulation activation in patients with colorectal cancer. Thromb Haemost 97:119-123, 2007
38. Khorana AA, Francis CW, Menzies KE, et al: Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer. J Thromb Haemost 6:1983-1985, 2008
39. Amirkhosravi A, Meyer T, Chang JY, et al: Tissue factor pathway inhibitor reduces experimental lung metastasis of B16 melanoma. Thromb Haemost 87:930-936, 2002
40. Mueller BM, Reisfeld RA, Edgington TS, et al: Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. Proc Natl Acad Sci U S A 89:11832-11836, 1992
41. Mueller BM, Ruf W: Requirement for binding of catalytically active factor VIIa in tissue factordependent experimental metastasis. J Clin Invest 101:1372-1378, 1998
42. Camerer E, Qazi AA, Duong DN, et al: Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis. Blood 104:397-401, 2004
43. Palumbo JS, Kombrinck KW, Drew AF, et al: Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood 96:3302-3309, 2000
44. Seto S, Onodera H, Kaido T, et al: Tissue factor expression in human colorectal carcinoma: Correlation with hepatic metastasis and impact on prognosis. Cancer 88:295-301, 2000
45. Palumbo JS, Talmage KE, Massari JV, et al: Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms. Blood 110:133-141, 2007
46. Palumbo JS, Talmage KE, Massari JV, et al: Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood 105:178-185, 2005
47. Contrino J, Hair G, Kreutzer DL, et al: In situ detection of tissue factor in vascular endothelial cells: Correlation with the malignant phenotype of human breast disease. Nat Med 2:209-215, 1996
48. Luther T, Flossel C, Mackman N, et al: Tissue factor expression during human and mouse development. Am J Pathol 149:101-113, 1996
49. Shoji M, Hancock WW, Abe K, et al: Activation of coagulation and angiogenesis in cancer: Immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer. Am J Pathol 152:399-411, 1998
50. Zhang Y, Deng Y, Luther T, et al: Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J Clin Invest 94:1320-1327, 1994
51. Carmeliet P, Mackman N, Moons L, et al: Role of tissue factor in embryonic blood vessel development. Nature 383:73-75, 1996
52. Griffin CT, Srinivasan Y, Zheng YW, et al: A role for thrombin receptor signaling in endothelial cells during embryonic development. Science 293: 1666-1670, 2001
53. Ruf W: Tissue factor and PAR signaling in tumor progression. Thromb Res 120:S7-S12, 2007 (suppl 2)
54. Hembrough TA, Swartz GM, Papathanassiu A, et al: Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism. Cancer Res 63:2997-3000, 2003
55. Milsom CC, Yu JL, Mackman N, et al: Tissue factor regulation by epidermal growth factor receptor and epithelial-to-mesenchymal transitions: Effect on tumor initiation and angiogenesis. Cancer Res 68:10068-10076, 2008
56. Versteeg HH, Schaffner F, Kerver M, et al: Inhibition of tissue factor signaling suppresses tumor growth. Blood 111:190-199, 2008
57. Versteeg HH, Schaffner F, Kerver M, et al: Protease-activated receptor (PAR) 2, but not PAR1, signaling promotes the development of mammary adenocarcinoma in polyoma middle T mice. Cancer Res 68:7219-7227, 2008
58. Hjortoe GM, Petersen LC, Albrektsen T, et al: Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration. Blood 103:3029-3037, 2004
59. Huang X, Molema G, King S, et al: Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature. Science 275:547-550, 1997
60. Bieker R, Kessler T, Schwoppe C, et al: Infarction of tumor vessels by NGR-peptide directed targeting of tissue factor: Experimental results and first-in-man experience. Blood 113:5019-5027, 2009
61. Hu Z, Garen A: Intratumoral injection of adenoviral vectors encoding tumor-targeted immunoconjugates for cancer immunotherapy. Proc Natl Acad Sci U S A 97:9221-9225, 2000
62. Hu Z, Garen A: Targeting tissue factor on tumor vascular endothelial cells and tumor cells for immunotherapy in mouse models of prostatic cancer. Proc Natl Acad Sci U S A 98:12180-12185, 2001
63. Hu Z, Sun Y, Garen A: Targeting tumor vasculature endothelial cells and tumor cells for immunotherapy of human melanoma in a mouse xenograft model. Proc Natl Acad Sci U S A 96:8161-8166, 1999